Zhen-Hua Zhou
Overview
Explore the profile of Zhen-Hua Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun J, Chen Z, Liu S, Ye F, Tang T, Zhou Z, et al.
Adv Radiat Oncol
. 2025 Jan;
10(2):101690.
PMID: 39871950
Purpose: The objective of this study was to explore the performance of a predictive model for swallowing-induced breakthrough pain established using a redefined delineation method based on the common occurrence...
2.
Chen G, Li M, Yang J, Zhou Z
Am J Cancer Res
. 2024 Aug;
14(7):3241-3258.
PMID: 39113872
Cancer is the disease that poses the greatest threat to human health today. Among them, hepatocellular carcinoma (HCC) is particularly prominent due to its high recurrence rate and extremely low...
3.
Shao R, Niu X, Xu X, Zhou Z, Chu S, Tong L, et al.
Nano Lett
. 2024 Apr;
24(18):5578-5584.
PMID: 38682925
The lattice parameter of platinum-based intermetallic compounds (IMCs), which correlates with the intrinsic activity of the oxygen reduction reaction (ORR), can be modulated by crystal phase engineering. However, the controlled...
4.
Shao R, Xu X, Zhou Z, Zeng W, Song T, Yin P, et al.
Nat Commun
. 2023 Sep;
14(1):5896.
PMID: 37736762
Carbon supported intermetallic compound nanoparticles with high activity and stability are promising cathodic catalysts for oxygen reduction reaction in proton-exchange-membrane fuel cells. However, the synthesis of intermetallic catalysts suffers from...
5.
Zhang J, Zhang X, Zhou Z, Zhu X, Zheng C, Li M, et al.
Evid Based Complement Alternat Med
. 2022 Apr;
2022:6097221.
PMID: 35368769
Background: Bushen Jianpi formula (BSJPF, also known as Lingmao formula) is a traditional Chinese medicine for chronic hepatitis B (CHB). The previous study has suggested that the treatment combination of...
6.
Li Q, Tan J, He Y, Bai F, Li S, Hou Y, et al.
Int J Biol Sci
. 2022 Mar;
18(4):1594-1611.
PMID: 35280674
Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver diseases worldwide. At present, there are no effective pharmacological therapies for NAFLD except lifestyle intervention-mediated weight loss....
7.
Ji L, Gao Q, Guo R, Zhang X, Zhou Z, Yu Z, et al.
J Immunol Res
. 2022 Feb;
2022:7931597.
PMID: 35127955
[This corrects the article DOI: 10.1155/2019/8983903.].
8.
Chen Y, Liu L, Li M, Xu R, Qu W, Yin J, et al.
J Tradit Chin Med
. 2021 Dec;
41(6):862-874.
PMID: 34939382
Objective: To investigate the chemical characters of water-extract of Baqi Lingmao formula (BQLM formula) and its effects on anti-liver injury in model mice and live cells. Methods: BQLM formula was...
9.
Xu L, Liao J, Liu L, Zhao L, Liu S, Chen Y, et al.
J Clin Neurosci
. 2021 Jun;
89:171-176.
PMID: 34119264
Cardiac embolism is the leading etiology of ischemic strokes. There are arguments about the left-right propensity of cardioembolic strokes.This study aimed to reveal the relationship between the different aortic arch...
10.
Hou Z, Zhang J, Zhang X, Ling Q, Zheng C, Zhu X, et al.
Evid Based Complement Alternat Med
. 2020 Aug;
2020:3826857.
PMID: 32831863
Objective: To evaluate the impact of long-term Traditional Chinese Medicine (TCM) syndrome differentiation combined with antiviral therapy with Nucleos (t) ide analogues (NAs) on the incidence of cirrhosis in patients...